Type IV collagen was isolated from human kidney cortex according to the purification of mouse kidney type IV collagen (MKIVC) with minor modifications as described previously [Oikawa, T., et al. (1986) Chem. Pharm. Bull. 34, 789-797]. Chromatography of human kidney type IV collagen (HKIVC) on a column of DEAE-cellulose resulted in its separation into two fractions, i.e., one (HKIVC-1) passed through and the other (HKIVC-2) adsorbed to the column, similar to MKIVC. Sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) and Bio-Gel A-5m chromatography revealed that both HKIVC-1 and -2 differed from each other in the ratios of major and minor components. Amino acid analyses also demonstrated that there was a significant difference in the contents of several amino acid residues between both type IV collagens and their 80-kDa components, one of the major ones. These results indicate the possibility that there exist two forms of type IV collagen in human kidney.
Download full-text PDF |
Source |
|---|
Publication Analysis
Top Keywords
Similar Publications
Early administration of romosozumab prevents rebound of bone resorption related to denosumab withdrawal in fractured post-menopausal women: a real-world prospective study.
J Endocrinol Invest
January 2025
Department of Biomedical Sciences, Humanitas University, Pieve Emanuele (MI), Via Rita Levi Montalcini 4, Milan, Italy.
Purpose: The real-world effectiveness of switching from denosumab to romosozumab remains controversial. Sequential therapy with romosozumab was shown to be associated with inadequate suppression of bone resorption and there was anecdotal evidence of major osteoporotic fractures (MOFs) after transitioning from denosumab to romosozumab. This study evaluated the effects on bone resorption of early romosozumab administration 3 months after denosumab withdrawal in fractured women with post-menopausal osteoporosis.
View Article and Find Full Text PDFLamellarin D Acts as an Inhibitor of Type I Collagen Production.
ChemMedChem
January 2025
Nagasaki University Graduate School of Biomedical Sciences: Nagasaki Daigaku Daigakuin Ishiyakugaku Sogo Kenkyuka, Department of Respiratory Medicine, JAPAN.
Idiopathic pulmonary fibrosis (IPF) is a progressive and chronic interstitial lung disease characterized by irreversible loss of lung function and a poor prognosis. Type I collagen, a major component of the extracellular matrix, plays a central role in the pathogenesis of fibrosis and is considered a key molecular target for therapeutic intervention. While current anti-fibrotic therapies demonstrate limited efficacy in slowing disease progression, their clinical impact remains suboptimal due to poor pharmacokinetic properties and non-curative therapy.
View Article and Find Full Text PDF[Hybrid wound coating in rehabilitation of severe thermal burns. (An experimental study)].
Vopr Kurortol Fizioter Lech Fiz Kult
January 2025
Petrovsky National Research Centre of Surgery, Moscow, Russia.
Unlabelled: One of the tasks of restorative medicine is the rehabilitation of the body that has suffered from injuries, diseases or adverse environmental effects, and the restoration of the functional reserves of the human body. Currently, a search is underway for new treatment technologies, including the use of wound dressings with specified functional qualities.
Objective: To characterize the effect of a wound dressing based on an ion-track membrane modified with collagen and chitosan nanofibers on the efficiency of skin restoration in experimental animals after a severe thermal burn.
Injection of Different Concentrations of Recombinant Humanized Type III Collagen Into the Dermis Promotes Type III and Type I Collagen Deposition as Well as Angiogenesis: An In Vivo Study.
Dermatol Surg
January 2025
All authors are affiliated with the Department of Plastic Surgery, Peking University Third Hospital, Haidian District, Beijing, China.
Background: Type III recombinant humanized collagen (rhCol III) has a promising future in cosmetic applications.
Objective: To investigate the histological changes associated with injection of different concentrations of Type III rhCol III into the dermis.
Materials And Methods: Twenty mice were divided into a control, low-dose (LD) group, and high-dose (HD) group.
Bipyramidal gold nanoparticles-assisted plasmonic photothermal therapy for ocular applications.
J Mater Chem B
January 2025
Maimonides Biomedical Research Institute of Cordoba (IMIBIC), Department of Ophthalmology, Reina Sofia University Hospital and University of Cordoba, 14004 Cordoba, Spain.
Gold nanoparticles (AuNPs) play a key role in the field of nanomedicine due to their fascinating plasmonic properties as well as their great biocompatibility. An intriguing application is the use of plasmonic photothermal therapy (PPTT) mediated by anisotropic AuNPs irradiated with a near-infrared (NIR) laser for treating ocular diseases in ophthalmology. For this purpose, bipyramidal-shaped AuNPs (BipyAu), which were surface-functionalized with three different organic ligands (citrate, polystyrene sulphonate (PSS), and cetyltrimethylammonium bromide (CTAB)), were synthesized.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!